Early laryngeal cancer; the tumor is modest in stages 0, 1, and 2. The cancer has not gone past the larynx. Hoarseness or a change in voice are common symptoms of laryngeal tumors that grow on the vocal cords (glottis). Removing cancer through surgery is a common treatment for all stages of laryngeal cancer.
Laser treatment was developed in the early 1970s as a method of treating laryngeal disease with accuracy and with little heat injury to the voice cords.
LLT has been a key aspect of the therapy paradigm for patients with laryngeal cancer, particularly early-stage laryngeal malignancies, over the previous four decades.
Without a doubt, the quality of the laser devices utilized for therapy was a decisive element that had a significant influence on the quality and duration of the recovery.
The FDA Portable Surgery Diode Laser System LASER-1.2B for example has been recurrently used by a number of otolaryngologists viewing its high efficacy in treating such an issue.
This device’s blue laser light interacts better with the tissue components hemoglobin or melanin. At 980 nm, the machine performs better and gentler cutting, even at lower power.
As such, its Improved cutting performance makes it ideally suited to all surgical applications particularly removing laryngeal cancer.
What also makes the LASER-1.2B highly recommended by otolaryngologists is that it displays an accurate alignment and exact sighting during the treatment. All thanks to its green aiming beam.
The equipment is aided by a fiber guide laser, which improves the therapy even more. For starters, it is suitable for a variety of endoscopic applications. Second, these unique fibers are sterilizable, which prevents cross-infection while ensuring a clean and bloodless operational region.
With a maximum power of 15W and a wavelength of 980nm, the device is anticipated to be ideal for very sensitive laryngeal cancer procedures.
That is highly attributed to the fact that The LASER-1.2 B uses infrared wavelengths and ultra-blue light to ensure high-level performance. That actually reduces the thermal damage and its peculiar interaction with hemoglobin.
Due to all these features, the LASER-1.2B guarantees increased cutting effectiveness, much higher than the one obtained with infrared lasers.
Additionally, the complete absence of water absorption helps drastically reduce the overheating of the surrounding tissues. This should further reinforce the laser treatment’s efficacy.
Lasers are a newer element to laryngeal surgery. Laser use and applications have grown dramatically since their creation. In this article, we will explore the advantages of laser therapy and, more specifically, the usefulness of LASER-1.2B as a surgical laser device in the treatment of such disorders.
Reference: Guidance of laser therapy for early laryngeal carcinoma by mucosal wave changes,
Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFLASER is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each Laser System.
The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional